A. Leyva
Impact in
- Physiology top 2%
- Adenosine and Purinergic Signaling
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
Papers in
-
- Biochemical and Molecular Research 23
- Cancer therapeutics and mechanisms 5
- Oncology 16
- Co-authors
- Herbert M. Pinedo (33 shared papers)Godefridus J. Peters (22 shared papers)William N. Kelley (4 shared papers)D. R. Huismans (3 shared papers)Rob Pieters (3 shared papers)E. Laurensse (12 shared papers)Emile J. Laurensse (3 shared papers)Jan Lankelma (5 shared papers)
- Journals
- Advances in experimental medicine and biology (6 papers)Biochemical Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Cancer Letters (3 papers)Analytical Biochemistry (2 papers)
- Partner nations
- NetherlandsUnited StatesBrazil
In The Last Decade
A. Leyva
74 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 112
- Physiology 117
- Oncology 617
- Molecular Biology 1.1k
- Hematology 158
- Cancer Research 198
Countries citing papers authored by A. Leyva
This map shows the geographic impact of A. Leyva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Leyva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Leyva more than expected).
Fields of papers citing papers by A. Leyva
This network shows the impact of papers produced by A. Leyva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Leyva. The network helps show where A. Leyva may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Leyva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. | 1986 | 177 |
| 2 | 1974 | 150 | |
| 3 | 1988 | 132 | |
| 4 | 1989 | 116 | |
| 5 | Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients. | 1986 | 106 |
| 6 | 1987 | 76 | |
| 7 | Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. | 1984 | 75 |
| 8 | 1999 | 70 | |
| 9 | Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicity. | 1986 | 70 |
| 10 | 1988 | 62 | |
| 11 | 1993 | 53 | |
| 12 | 1987 | 50 | |
| 13 | 2000 | 46 | |
| 14 | 1975 | 34 | |
| 15 | 1987 | 34 | |
| 16 | 1984 | 32 | |
| 17 | 1986 | 32 | |
| 18 | 1988 | 31 | |
| 19 | 1984 | 28 | |
| 20 | 2001 | 26 |
About A. Leyva
A. Leyva is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health, having authored 78 papers that have together received 1.9k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (23 papers), HIV/AIDS drug development and treatment (13 papers), Acute Lymphoblastic Leukemia research (8 papers), Adenosine and Purinergic Signaling (8 papers), Click Chemistry and Applications (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Physiology (117 citations), Oncology (617 citations), Molecular Biology (1.1k citations), Hematology (158 citations) and Cancer Research (198 citations). A. Leyva has collaborated with scholars based in Netherlands, United States and Brazil. Frequent co-authors include Herbert M. Pinedo, Godefridus J. Peters, William N. Kelley, D. R. Huismans, Rob Pieters, E. Laurensse, Emile J. Laurensse, Jan Lankelma, J. Lankelma and C.J. van Groeningen. Their work appears in journals such as Advances in experimental medicine and biology, Biochemical Pharmacology, Cancer Chemotherapy and Pharmacology, Cancer Letters and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.